Nowadays, numerous traditional Chinese medicine monomer inhibitors have been identified that inhibit OXPHOS, including Demethylzeylasteral [50], the extract of Cortex Periplocae, known as Periplocymarin (PPM) [51], and a novel peptide inhibitor of C1QBP that impairs mitochondrial function and targets triple-negative breast cancer [52]. Here, C1QBP is linked to triple-negative breast carcinoma.